Sohini Das

India breaks into the top 15 markets for Mercedes-Benz, says Mathias Geisen

India is now among Mercedes-Benz's top 15 global markets and top five for Maybach as the carmaker bets on rising wealth and luxury demand

JLR doubles down on North America as China shows signs of stabilising

Jaguar will go all-electric, while Range Rover and Defender retain hybrid and combustion options as JLR pivots towards North America and future growth markets

India's pharma market gets a lift from rising volumes, not just prices

Chronic therapies and GLP-1 adoption help broaden growth drivers as the market expands over 10 per cent in April and May

Tata Motors charts shift to software-led vehicles with t.idal platform

SDV strategy to complement pipeline of new launches across ICE, CNG and EV segments

Biopharma entering innovation power decade, says Bernstein report

Brokerage says India should focus on specialty medicines and incremental innovation rather than copying Big Pharma's new-drug discovery model

Small cars, SUVs drive passenger vehicle sales to record high in May

Scooters powered highest-ever 2W volumes, shows Siam data

Novartis brings India's first 'guided missile' therapy for prostate cancer

Novartis launches Pluvicto, a precision treatment that delivers radiation directly to cancer cells

Mercedes to expand PHEV line-up as buyers still prefer conventional cars

Mercedes-Benz India said plug-in hybrids could play a bigger role in its portfolio as most luxury-car buyers continue to favour conventional powertrains despite rising electric-vehicle adoption

Piramal Pharma to stay away from generic GLP-1 race amid global rush

Piramal Pharma is avoiding the crowded GLP-1 peptide market, focusing instead on niche therapies and specialised manufacturing to drive CDMO growth in FY27

Beyond Zaynich: Wockhardt bets on WCK 6777 as next blockbuster jab

Once-a-day injectable antibiotic aimed at treatment beyond hospitals through outpatient centres

Wockhardt targets 50% of revenue from novel drugs within five years

Wockhardt expects novel drugs to contribute over half its revenue within five years as it expands a differentiated antibiotic portfolio built through decades of R&D

Cancer drug shortage: Drugmaker Naprod seeks one-time price hike

Says higher import duties, regulatory hurdles have made chemo drugs' production unviable

Electric vehicle retail sales up 45% in May; ePVs and e2Ws drove adoption

India's EV sales surged 45% to a record 2.72 lakh units in May, pushing overall EV penetration above 11% for the first time amid rising fuel costs

Drug companies seek NPPA price revision for cancer drugs amid shortage

Oncology drugmaker says soaring platinum prices, higher import duties and lengthy import approvals have made production financially unviable, worsening shortages of key chemotherapy medicines

M&M bets beyond tractors to drive farm mechanisation and rural enterprise

Expands focus beyond tractors into harvesters, seed drills and telematics-led services

Services, digital business emerge as drivers of TaMo CV arm's earnings

Iveco seen as technology and global expansion platform; EVs and hydrogen remain central to future strategy

Tata Motors CV ready for next phase, but challenges ahead: N Chandrasekaran

Tata Motors chairman says the commercial vehicles business is poised for growth after the demerger, with technology, innovation and global expansion driving strategy

Centre's ₹9,585-cr green scheme for NCR may boost CV replacement demand

The two-year programme aims to replace over 2 lakh ageing trucks and buses across Delhi-NCR through interest subsidies, tax waivers and manufacturer discounts

Ceat bets on CAMSO to drive next phase of off-highway tyre growth

The tyre maker expects tracks and developed markets such as North America and Europe to power growth as access to additional CAMSO categories expands

Wockhardt eyes $1.5 bn peak sales from Zaynich, targets US launch by yr-end

Novel antibiotic to be launched in India around the same time; company to commercialise product on its own in US